Health Catalyst Past Earnings Performance
Past criteria checks 0/6
Health Catalyst has been growing earnings at an average annual rate of 13.3%, while the Healthcare Services industry saw earnings growing at 23.3% annually. Revenues have been growing at an average rate of 14.2% per year.
Key information
13.3%
Earnings growth rate
48.9%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 14.2% |
| Return on equity | -22.3% |
| Net Margin | -26.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Health Catalyst: Improved Demand Environment Reinforces My Buy Rating
Dec 18Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets
Sep 24Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business
Jul 17
Health Catalyst: Stellar Earnings Growth Projected
Jun 26Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price
Apr 04Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible
Mar 09Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)
Feb 16Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?
Jan 27What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You
Dec 24Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?
Dec 15Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?
Oct 24Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price
Jul 31Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Jun 27Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Feb 22Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate
Dec 06Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?
Nov 03Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate
Oct 14Health Catalyst names Kevin Freeman as Chief Growth Officer, Tarah Bryan as Chief Marketing Officer, Dave Ross as Chief Technology Officer
Sep 07Revenue & Expenses Breakdown
How Health Catalyst makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 302 | -79 | 103 | 59 |
| 30 Jun 24 | 299 | -86 | 108 | 62 |
| 31 Mar 24 | 297 | -106 | 112 | 66 |
| 31 Dec 23 | 296 | -118 | 111 | 69 |
| 30 Sep 23 | 290 | -124 | 121 | 69 |
| 30 Jun 23 | 285 | -147 | 131 | 70 |
| 31 Mar 23 | 282 | -148 | 130 | 69 |
| 31 Dec 22 | 276 | -137 | 144 | 69 |
| 30 Sep 22 | 272 | -151 | 144 | 68 |
| 30 Jun 22 | 265 | -145 | 143 | 67 |
| 31 Mar 22 | 254 | -147 | 148 | 64 |
| 31 Dec 21 | 242 | -153 | 132 | 62 |
| 30 Sep 21 | 230 | -147 | 123 | 60 |
| 30 Jun 21 | 216 | -135 | 112 | 57 |
| 31 Mar 21 | 200 | -126 | 102 | 55 |
| 31 Dec 20 | 189 | -115 | 96 | 54 |
| 30 Sep 20 | 179 | -86 | 89 | 52 |
| 30 Jun 20 | 171 | -99 | 90 | 52 |
| 31 Mar 20 | 165 | -181 | 85 | 49 |
| 31 Dec 19 | 155 | -241 | 79 | 46 |
| 30 Sep 19 | 148 | -304 | 76 | 44 |
| 30 Jun 19 | 141 | -282 | 69 | 41 |
| 31 Mar 19 | 127 | -190 | 71 | 39 |
| 31 Dec 18 | 113 | -114 | 66 | 38 |
| 31 Dec 17 | 73 | -59 | 41 | 28 |
Quality Earnings: HCAT is currently unprofitable.
Growing Profit Margin: HCAT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HCAT is unprofitable, but has reduced losses over the past 5 years at a rate of 13.3% per year.
Accelerating Growth: Unable to compare HCAT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HCAT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (17.5%).
Return on Equity
High ROE: HCAT has a negative Return on Equity (-22.29%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 03:53 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Health Catalyst, Inc. is covered by 22 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhilin Long | Berenberg |
| David Larsen | BTIG |
| Richard Close | Canaccord Genuity |